-+ 0.00%
-+ 0.00%
-+ 0.00%

PRECISION MEDICINE PORTFOLIO UPDATE: ILLUCCIX CHINA PHASE 3 STUDY, TLX101-CDX AND TLX250-CDX FDA RESUBMISSIONS

Reuters·12/21/2025 21:38:27

Please log in to view news